Ulrike Samulowitz

This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Coley Pharmaceutical Gmbh, Coley Pharmaceutical Group, Inc., Pfizer Corporation. Active years: 2009-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulrike Samulowitz. Retrieved from https://idiyas.com/inventor/ulrike-samulowitz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 3)

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 5.1

ph-index = 5

Forward Citations = 129(Granted Patents)

Company Filing History:

5 out of 27

Coley Pharmaceutical Gmbh

patents

5 out of 41

Coley Pharmaceutical Group, Inc.

where one patent can have more than one assignee

Years Active: 2009-2012

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8304396 - Immunostimulatory nucleic acids (2012-11-06),

2. 8283328 - Immunostimulatory nucleic acids (2012-10-09),

3. 8198251 - Combination motif immune stimulatory oligonucleotides with improved activity (2012-06-12),

4. 7795235 - Semi-soft c-class immunostimulatory oligonucleotides (2010-09-14),

5. 7566703 - Semi-soft C-class immunostimulatory oligonucleotides (2009-07-28),

Title: The Innovative Journey of Ulrike Samulowitz

Introduction

Ulrike Samulowitz, a pioneering inventor based in Langenfeld, Germany, has made significant contributions to the field of immunology. With a strong focus on immunostimulatory nucleic acids, her innovative work has garnered her a total of five patents. Her research aims to enhance immune responses, paving the way for advancements in medical treatments and therapies.

Latest Patents

Among her latest inventions, Ulrike's notable patents include a class of soft or semi-soft CpG immunostimulatory oligonucleotides. This work is crucial for stimulating an immune response, showcasing her commitment to addressing health challenges through groundbreaking methodologies in immunology.

Career Highlights

Throughout her career, Ulrike has been associated with reputable organizations, including Coley Pharmaceutical Group, Inc. and Coley Pharmaceutical GmbH. Her roles in these companies have enabled her to apply her expertise and creative thinking to develop innovative solutions in the pharmaceutical industry.

Collaborations

Ulrike has collaborated with esteemed colleagues such as Arthur Mertz Krieg and Eugen Uhlmann. These partnerships have fostered a dynamic exchange of ideas and expertise, further enhancing her contributions to the field of immunology and innovations in health care.

Conclusion

Ulrike Samulowitz exemplifies the spirit of innovation through her dedication to research and development in immunostimulatory nucleic acids. Her achievements and collaborative efforts continue to impact the pharmaceutical landscape, inspiring future generations of inventors and researchers.

Profile summary based on public USPTO records.